Taurine trials report lower cardiometabolic risk markers
Trial results favored taurine for several blood-pressure, glucose and lipid measures, without establishing fewer cardiovascular events or diabetes diagnoses.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
The pooled trials reported reductions in several cardiometabolic markers with taurine, including blood pressure, glucose and cholesterol measures. These results describe measured risk factors, not demonstrated prevention of disease. Although the authors suggest possible future disease benefits, the abstract does not report heart attacks, strokes or new diagnoses as outcomes of supplementation.
Participant health profiles, control treatments and adverse-event findings are absent from the abstract. These omissions limit how confidently its marker results can be applied to particular groups.
What researchers found
Systolic blood pressure
Average systolic pressure was lower with taurine; comparator treatments and assessment timing for this pooled estimate were not specified.
What the abstract covers
Researchers pooled randomized trials and summarized outcomes using mean differences or standardized mean differences. The measures covered glucose regulation, blood lipids, blood pressure and several additional laboratory markers, rather than a single clinical endpoint.
Subgroup claims need detail
The abstract describes dose and duration subgroup analyses but gives no subgroup effect estimates or uncertainty. Its claims about preferable regimens therefore cannot identify a reliably superior dose or treatment length for an individual.
The original publication
Effects of Oral Taurine Supplementation on Cardiometabolic Risk Factors: A Meta-analysis and Systematic Review of Randomized Clinical Trials.
Nie Z, Liu Y, Zhang M et al.
Nutr Rev · 2026
- PubMed ID
- 41275513
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.